Starling Oncology (STLNW) Amortizatization of Intangibles (2022 - 2024)

Starling Oncology (STLNW) has reported Amortizatization of Intangibles for 3 consecutive years, with $1000.0 the latest figure, recorded in Q4 2024.

• For the quarter ending Q4 2024, Amortizatization of Intangibles fell 99.95% year-over-year to $1000.0; the trailing twelve-month figure through Sep 2025 stood at $1000.0 (down 99.96% YoY), and the FY2024 full-year result was $500000.0, down 81.0% from the prior year.
• Amortizatization of Intangibles fell to $1000.0 in Q4 2024 per STLNW's latest filing, from $48000.0 in the prior quarter.
• Across five years, Amortizatization of Intangibles topped out at $1.9 million in Q4 2023 and bottomed at -$877000.0 in Q3 2023.
• Historically, Amortizatization of Intangibles has averaged $415100.0 across 3 years, with a median of $225500.0 in 2024.
• The sharpest annual moves came in 2023 and 2024: Amortizatization of Intangibles plunged 3124.14% in 2023, then jumped 105.47% in 2024.
• Over 3 years, Amortizatization of Intangibles stood at $991000.0 in 2022, then soared by 93.64% to $1.9 million in 2023, then tumbled by 99.95% to $1000.0 in 2024.
• According to Business Quant data, Amortizatization of Intangibles over the past three periods registered $1000.0, $48000.0, and $127000.0 for Q4 2024, Q3 2024, and Q2 2024 respectively.